Diabetic ketoacidosis inpatient management algorithm (adults)
DKA management is recommended using an IV fluids–insulin–potassium replacement pathway with frequent monitoring of electrolytes and ketone clearance based on the 2024 ADA/EASD/JBDS/AACE/DTS consensus report ADA 2024 Hyperglycemic crises in adults.
Stepwise treatment targets ketone resolution and metabolic acidosis correction with safe electrolyte replacement and avoidance of treatment-related hypoglycemia ADA 2024 Hyperglycemic crises in adults, [1].
Diagnosis and severity stratification
DKA is diagnosed when hyperglycemia or suspected insulin deficiency is accompanied by ketonemia/ketonuria and metabolic acidosis ADA 2024 Hyperglycemic crises in adults.
Initial severity assessment should include venous or arterial blood gas with pH and bicarbonate, serum electrolytes (including potassium), creatinine, and ketone measurement ADA 2024 Hyperglycemic crises in adults.
Coexisting causes requiring treatment should be actively evaluated, including infection, missed insulin, and other precipitants ADA 2024 Hyperglycemic crises in adults.
Step 1: Initial stabilization and fluid resuscitation
Initial IV isotonic crystalloid resuscitation is recommended to restore circulating volume and improve tissue perfusion ADA 2024 Hyperglycemic crises in adults, [1].
A “fixed-dose” approach to insulin is not a substitute for prompt fluid replacement ADA 2024 Hyperglycemic crises in adults.
Fluid balance and urine output should be monitored closely due to the high risk for volume overload in vulnerable patients ADA 2024 Hyperglycemic crises in adults.
Step 2: Potassium replacement integrated with insulin initiation
Serum potassium should be checked immediately before insulin therapy because insulin drives potassium intracellularly during DKA treatment ADA 2024 Hyperglycemic crises in adults, [1].
Insulin should be delayed in the setting of severe hypokalemia until potassium is corrected to a safe range [1].
Potassium replacement should be continued during insulin therapy based on serial potassium measurements ADA 2024 Hyperglycemic crises in adults.
Step 3: IV insulin infusion for ketone clearance
IV regular insulin infusion is recommended to suppress ketogenesis and clear existing ketones ADA 2024 Hyperglycemic crises in adults.
Fixed-rate IV insulin strategies are endorsed in DKA pathways to reduce variability in ketosis management [1].
When blood glucose declines to avoid hypoglycemia during ongoing ketosis clearance, dextrose is added to maintain the ability to continue insulin at a rate that resolves ketosis [1], Kohler & Levy JBDS summary.
Step 4: Glucose and insulin rate adjustments during treatment
Blood glucose should be monitored frequently during treatment to guide dextrose addition Kohler & Levy JBDS summary.
Dextrose should be added when glucose reaches a threshold where continued insulin without dextrose would risk hypoglycemia [1], Kohler & Levy JBDS summary.
The insulin infusion rate can require de-escalation near the point of falling glucose to reduce hypoglycemia risk while continuing ketosis resolution [1].
Step 5: Bicarbonate and adjunctive therapy
Routine bicarbonate therapy is not a default requirement in DKA management in most pathways because insulin and fluids address the underlying ketoacidosis ADA 2024 Hyperglycemic crises in adults.
Bicarbonate use should be reserved for specific indications based on acid-base severity as described in consensus guidance ADA 2024 Hyperglycemic crises in adults.
Complication prevention includes careful management of electrolytes and monitoring for cerebral edema risk factors in appropriate populations ADA 2024 Hyperglycemic crises in adults.
Monitoring targets and treatment end points
Bedside and laboratory monitoring should be performed frequently, with serial glucose and electrolytes tracked at short intervals during the initial phase Kohler & Levy JBDS summary.
Ketone clearance should be tracked directly using ketone measurements or a validated surrogate pathway described in consensus protocols ADA 2024 Hyperglycemic crises in adults, Kohler & Levy JBDS summary.
Treatment should continue until ketosis resolves and metabolic acidosis improves, guided by ketone clearance plus improving acid-base parameters ADA 2024 Hyperglycemic crises in adults.
Transition from IV insulin to subcutaneous insulin
Subcutaneous basal insulin should be initiated in a timely manner to prevent rebound hyperglycemia and ketosis after stopping the IV infusion ADA 2024 Hyperglycemic crises in adults, Kohler & Levy JBDS summary.
Long-acting insulin should be continued when already used before admission and when clinically appropriate, per inpatient DKA pathways Kohler & Levy JBDS summary.
The IV insulin infusion should be discontinued only after an adequate overlap period and clinical stability consistent with the transition plan ADA 2024 Hyperglycemic crises in adults.
Common pitfalls to avoid
Insulin administration without confirming safe potassium levels increases risk for clinically significant hypokalemia during treatment ADA 2024 Hyperglycemic crises in adults, [1].
Failure to add dextrose when glucose falls increases risk of hypoglycemia and may force early reduction of insulin that delays ketosis resolution [1], Kohler & Levy JBDS summary.
Premature discontinuation of IV insulin without an appropriate basal insulin plan increases risk of recurrent ketoacidosis ADA 2024 Hyperglycemic crises in adults.
Precipitant management and relapse prevention
The precipitating cause should be identified and treated concurrently, including infection evaluation and management of insulin omission or therapy failure ADA 2024 Hyperglycemic crises in adults.
Education on recognition of early hyperglycemia/ketosis symptoms and adherence support is recommended to reduce recurrence risk after discharge ADA 2024 Hyperglycemic crises in adults.